KEGG   PATHWAY: ocu05213
Entry
ocu05213                    Pathway                                
Name
Endometrial cancer - Oryctolagus cuniculus (rabbit)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
ocu05213  Endometrial cancer
ocu05213

Disease
H00026  Endometrial cancer
Organism
Oryctolagus cuniculus (rabbit) [GN:ocu]
Gene
100008806  [KO:K04361] [EC:2.7.10.1]
100008808  [KO:K04357]
100009292  TP53; cellular tumor antigen p53 [KO:K04451]
100009316  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
100009554  [KO:K05083] [EC:2.7.10.1]
100101592  [KO:K04399] [EC:3.4.22.62]
100125985  [KO:K02105]
100327265  MYC; myc proto-oncogene protein [KO:K04377]
100328952  CTNNA1; catenin alpha-1 [KO:K05691]
100337822  [KO:K00922] [EC:2.7.1.153]
100337912  [KO:K08734]
100339216  [KO:K02620]
100339765  [KO:K04385]
100340437  [KO:K08845] [EC:2.7.11.1]
100340471  [KO:K04490]
100340952  [KO:K04375]
100342046  [KO:K14021]
100342500  [KO:K04364]
100342852  [KO:K04456] [EC:2.7.11.1]
100343241  [KO:K05691]
100343573  [KO:K09408]
100344241  [KO:K07828]
100345181  [KO:K00922] [EC:2.7.1.153]
100345250  [KO:K02649]
100346391  [KO:K03099]
100347345  [KO:K04371] [EC:2.7.11.24]
100347407  [KO:K04366] [EC:2.7.11.1]
100347487  [KO:K07827]
100347954  [KO:K06276] [EC:2.7.11.1]
100348127  [KO:K02157]
100348489  [KO:K06625]
100348561  [KO:K04371] [EC:2.7.11.24]
100348663  [KO:K00922] [EC:2.7.1.153]
100348842  [KO:K03083] [EC:2.7.11.26]
100351964  [KO:K04365] [EC:2.7.11.1]
100352218  [KO:K03511] [EC:2.7.7.7]
100352386  [KO:K10140]
100352391  [KO:K05691]
100352691  [KO:K04492]
100353284  [KO:K04402]
100353706  [KO:K04456] [EC:2.7.11.1]
100353742  [KO:K04402]
100353976  [KO:K02085]
100355675  [KO:K02159]
100355759  [KO:K06272] [EC:2.7.11.1]
100356548  [KO:K05689]
100356615  [KO:K03099]
100357841  [KO:K02649]
100358378  [KO:K04491]
100358587  [KO:K02158]
100358716  [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
103346018  [KO:K02085]
127485674  [KO:K02085]
127486116  [KO:K04456] [EC:2.7.11.1]
127486605  [KO:K02833]
127489236  [KO:K07827]
127489461  [KO:K04368] [EC:2.7.12.2]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
ocu04010  MAPK signaling pathway
ocu04012  ErbB signaling pathway
ocu04060  Cytokine-cytokine receptor interaction
ocu04110  Cell cycle
ocu04115  p53 signaling pathway
ocu04151  PI3K-Akt signaling pathway
ocu04310  Wnt signaling pathway
ocu04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system